These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17879973)

  • 1. A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams.
    Nonoyama A; Laurence JS; Garriques L; Qi H; Le T; Middaugh CR
    J Pharm Sci; 2008 Jul; 97(7):2552-67. PubMed ID: 17879973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenesis of the amylin analogue pramlintide.
    da Silva DC; Fontes GN; Erthal LC; Lima LM
    Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the thermal and pH stability of human respiratory syncytial virus.
    Ausar SF; Rexroad J; Frolov VG; Look JL; Konar N; Middaugh CR
    Mol Pharm; 2005; 2(6):491-9. PubMed ID: 16323956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus.
    Nyholm B; Møller N; Gravholt CH; Orskov L; Mengel A; Bryan G; Moyses C; Alberti KG; Schmitz O
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1083-9. PubMed ID: 8772580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
    da Silva DC; Lima LMTR
    Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ; Jobe LJ; Martin R
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.
    Kenley RA; Tracht S; Stepanenko A; Townsend M; L'Italien J
    AAPS PharmSciTech; 2000 Mar; 1(2):E7. PubMed ID: 14727840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
    Gingell JJ; Burns ER; Hay DL
    Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramlintide (Amylin).
    Barlocco D
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1575-81. PubMed ID: 11763160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation.
    Łoboda D; Rowińska-Żyrek M
    J Inorg Biochem; 2017 Sep; 174():150-155. PubMed ID: 28672144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.
    Edelman SV; Weyer C
    Diabetes Technol Ther; 2002; 4(2):175-89. PubMed ID: 12079621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.
    Hekman C; DeMond W; Dixit T; Mauch S; Nuechterlein M; Stepanenko A; Williams JD; Ye M
    Pharm Res; 1998 Apr; 15(4):650-9. PubMed ID: 9587964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1.
    Fan H; Li H; Zhang M; Middaugh CR
    J Pharm Sci; 2007 Jun; 96(6):1490-503. PubMed ID: 17094138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.
    Ramsey JD; Gill ML; Kamerzell TJ; Price ES; Joshi SB; Bishop SM; Oliver CN; Middaugh CR
    J Pharm Sci; 2009 Jul; 98(7):2432-47. PubMed ID: 19072858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes.
    Thompson RG; Gottlieb A; Organ K; Koda J; Kisicki J; Kolterman OG
    Diabet Med; 1997 Jul; 14(7):547-55. PubMed ID: 9223392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution behavior of IFN-beta-1a: an empirical phase diagram based approach.
    Fan H; Ralston J; Dibiase M; Faulkner E; Middaugh CR
    J Pharm Sci; 2005 Sep; 94(9):1893-911. PubMed ID: 16052555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
    Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
    Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal stability of adenovirus type 2 as a function of pH.
    Rexroad J; Martin TT; McNeilly D; Godwin S; Middaugh CR
    J Pharm Sci; 2006 Jul; 95(7):1469-79. PubMed ID: 16724322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20.
    Fan H; Vitharana SN; Chen T; O'Keefe D; Middaugh CR
    Mol Pharm; 2007; 4(2):232-40. PubMed ID: 17397238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.